fashion -WSS

fashion

author：Wikipedia 2025-09-30 17:03:05 - browse：5

Layoff concept illustration of empty desks and people walking away. — Adobe

Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biology called biomolecular condensates, laid off 15% of its staff on Tuesday and acknowledged that a pair of collaboration deals with pharma companies had fallen apart.

The downsizing is temporary, CEO Ameet Nathwani told STAT. The company needed to hire new employees with expertise to help move the company’s first drugs into clinical trials and expand its AI capabilities. And with funding for early-stage biotechs still sparse, leadership opted to cut some positions and use the savings to fill new ones over the coming months. Roughly 20 positions were cut.

“We talked to investors right now [about raising more money], and they think that the environment for a preclinical company — it’s not even worth having that discussion,” Nathwani said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Bird flu surveillance in wastewater gets boost from consortium

entertainment

WSS

Listen: A conversation with researcher Kevin Esvelt on biosecurity

'Screen and refer' systems are hurting patients

Prescription digital therapeutics are key to pharma’s future

Lupron, used to halt puberty in children, may cause lasting health problems

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

entertainment

fashion

focus

Supreme Court strikes down use of affirmative action

Fentanyl is making it harder to start addiction treatment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Moonlake's readout produced a cash windfall. Risks remain

AstraZeneca lung cancer study comes in below expectations

The high cost of giving birth even with insurance

UpToDate has a racism problem: Dr. Stanley Goldfarb

How one medical school became remarkably diverse

At flashy new research hub, AstraZeneca lays out ambitious growth goals

hotspot

Reports of telehealth's death have been greatly exaggerated

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Hubble vs. James Webb telescope images: See the difference

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Beware reading your test results before your doctor does

hotspot

entertainment

entertainment

leisure time